An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 0 | 4,070 |
| Other current assets | 0 | 164 |
| TOTAL | $0 | $4,234 |
| Non-Current Assets | ||
| TOTAL | $N/A | $N/A |
| Total Assets | $0 | $4,234 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 0 | 132 |
| Accrued Expenses | 0 | 1,313 |
| Other current liabilities | 0 | 14 |
| TOTAL | $0 | $1,459 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 0 | 24 |
| TOTAL | $N/A | $24 |
| Total Liabilities | $0 | $1,483 |
| Shareholders' Equity | ||
| Retained earnings | 0 | -20,319 |
| Other shareholders' equity | 0 | 23,070 |
| TOTAL | $0 | $2,751 |
| Total Liabilities And Equity | $0 | $4,234 |